Chembio Diagnostics to Participate in Upcoming Investor Conferences
May 26 2020 - 4:15PM
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading
point-of-care diagnostic company focused on infectious diseases,
today announced the company plans to participate in two upcoming
investor conferences.
Management is scheduled to participate in the
virtual 17th Annual Craig-Hallum Institutional Investor Conference
on Wednesday, May 27, 2020.
Management is also scheduled to participate in the
Benchmark Healthcare House Call Virtual Conference on Tuesday, June
16, 2020. Due to the format of these events no webcasts are
available.
About Chembio DiagnosticsChembio
is a leading point-of-care diagnostics company focused on detecting
and diagnosing infectious diseases, including COVID-19, sexually
transmitted disease, and fever and tropical disease. The company’s
patented DPP technology platform, which uses a small drop of blood
from the fingertip, provides high-quality, cost-effective results
in approximately 15 minutes. Coupled with Chembio’s extensive
scientific expertise, its novel DPP technology offers broad market
applications beyond infectious disease. Chembio’s products are sold
globally, directly and through distributors, to hospitals and
clinics, physician offices, clinical laboratories, public health
organizations, government agencies, and consumers. Learn more at
www.chembio.com.
DPP is Chembio’s registered trademark. For convenience, this
trademark appears in this release without ® symbols, but that
practice does not mean that Chembio will not assert, to the fullest
extent under applicable law, its rights to the trademark.
Contact: Philip TaylorGilmartin
Group(415) 937-5406investor@chembio.com
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Sep 2023 to Sep 2024